US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 1.8000
- 0.00000.00%
Trading Nov 19 15:48 ET
392.73MMarket Cap-8181P/E (TTM)
1.8200High1.7648Low965.53KVolume1.7900Open1.8000Pre Close1.74MTurnover0.49%Turnover RatioLossP/E (Static)218.18MShares2.480052wk High-7.79P/B356.89MFloat Cap0.800052wk Low--Dividend TTM198.27MShs Float31.0000Historical High--Div YieldTTM3.07%Amplitude0.2410Historical Low1.7980Avg Price1Lot Size
Akebia Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -10.98%37.43M | -22.58%43.65M | -18.49%32.61M | -33.46%194.62M | 0.74%56.2M | -13.69%42.05M | -55.39%56.38M | -35.16%40.01M | 38.19%292.48M | -3.29%55.78M |
| Operating revenue | -10.98%37.43M | -22.58%43.65M | -18.49%32.61M | -33.46%194.62M | 0.74%56.2M | -13.69%42.05M | -55.39%56.38M | -35.16%40.01M | 38.19%292.48M | -3.29%55.78M |
| Cost of revenue | -21.37%14.16M | -1.37%17.05M | -42.52%11.61M | -13.34%74.15M | 644.33%18.67M | -52.96%18.01M | -7.08%17.28M | -35.59%20.19M | -43.21%85.57M | -107.20%-3.43M |
| Gross profit | -3.20%23.27M | -31.95%26.6M | 5.99%21M | -41.78%120.47M | -36.61%37.53M | 130.39%24.04M | -63.72%39.09M | -34.72%19.82M | 239.32%206.92M | 489.16%59.21M |
| Operating expense | -3.07%35.77M | -26.68%35.33M | -20.81%35.88M | -38.72%166.55M | -42.48%36.16M | -39.16%36.9M | -18.56%48.18M | -49.01%45.31M | -16.50%271.76M | -16.62%62.86M |
| Selling and administrative expenses | 16.76%26.52M | -0.44%26.92M | 1.54%25.44M | -27.68%100.23M | -14.95%25.44M | -28.78%22.71M | -16.14%27.04M | -43.48%25.05M | -20.41%138.6M | -33.25%29.91M |
| Research and development costs | -36.33%8.49M | -62.14%7.65M | -50.57%9.73M | -51.47%63.08M | -69.27%9.87M | -52.44%13.33M | -22.40%20.2M | -55.09%19.69M | -12.08%129.99M | 8.60%32.1M |
| Other operating expenses | -11.00%769K | -19.70%762K | 25.18%711K | 1.95%3.24M | 0.47%856K | 16.29%864K | 6.39%949K | -17.44%568K | -9.00%3.18M | -17.20%852K |
| Operating profit | 2.81%-12.51M | 4.02%-8.73M | 41.63%-14.88M | 28.95%-46.08M | 137.67%1.37M | 74.38%-12.87M | -118.70%-9.09M | 56.42%-25.49M | 75.48%-64.85M | 94.42%-3.65M |
| Net non-operating interest income expense | -372.41%-6.66M | -30.88%-2.15M | -60.03%-2.5M | 61.55%-6.03M | 13.33%-1.42M | 64.32%-1.41M | 67.40%-1.64M | 69.16%-1.56M | 21.31%-15.69M | 67.81%-1.64M |
| Non-operating interest expense | 372.41%6.66M | 30.88%2.15M | 60.03%2.5M | -61.55%6.03M | -13.33%1.42M | -64.32%1.41M | -67.40%1.64M | -69.16%1.56M | --15.69M | --1.64M |
| Other net income (expense) | -311.79%-873K | 620.91%2.29M | -446.02%-609K | 101.33%182K | 183.50%658K | -361.73%-212K | 96.88%-440K | -84.48%176K | -667.23%-13.69M | -240.71%-788K |
| Gain on sale of security | ---856K | --2.33M | ---129K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special income (charges) | --0 | --0 | -442.45%-575K | 95.81%-705K | --0 | 84.44%-169K | 97.04%-430K | ---106K | ---16.84M | ---1.22M |
| -Less：Restructuring and merger&acquisition | --0 | --0 | -45.28%58K | -98.86%181K | --0 | -6.11%169K | -100.65%-94K | --106K | --15.93M | --1.22M |
| -Less:Other special charges | ---- | ---- | --517K | -42.16%524K | --0 | ---- | --524K | ---- | --906K | --0 |
| Other non- operating income (expenses) | 60.47%-17K | -290.00%-39K | -66.31%95K | -71.81%887K | 51.61%658K | -103.68%-43K | -102.43%-10K | -75.13%282K | 30.32%3.15M | -22.50%434K |
| Income before tax | -38.30%-20.04M | 23.18%-8.58M | 33.08%-17.99M | 44.89%-51.93M | 110.11%614K | 73.22%-14.49M | -137.94%-11.17M | 56.94%-26.88M | 66.59%-94.23M | 91.31%-6.07M |
| Income tax | ||||||||||
| Net income | -38.30%-20.04M | 23.18%-8.58M | 33.08%-17.99M | 44.89%-51.93M | 110.11%614K | 73.22%-14.49M | -137.94%-11.17M | 56.94%-26.88M | 66.59%-94.23M | 91.31%-6.07M |
| Net income continuous Operations | -38.30%-20.04M | 23.18%-8.58M | 33.08%-17.99M | 44.89%-51.93M | 110.11%614K | 73.22%-14.49M | -137.94%-11.17M | 56.94%-26.88M | 66.59%-94.23M | 91.31%-6.07M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -38.30%-20.04M | 23.18%-8.58M | 33.08%-17.99M | 44.89%-51.93M | 110.11%614K | 73.22%-14.49M | -137.94%-11.17M | 56.94%-26.88M | 66.59%-94.23M | 91.31%-6.07M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -38.30%-20.04M | 23.18%-8.58M | 33.08%-17.99M | 44.89%-51.93M | 110.11%614K | 73.22%-14.49M | -137.94%-11.17M | 56.94%-26.88M | 66.59%-94.23M | 91.31%-6.07M |
| Basic earnings per share | -25.00%-0.1 | 33.33%-0.04 | 40.00%-0.09 | 46.15%-0.28 | 108.07%0.0032 | 72.41%-0.08 | -137.50%-0.06 | 57.14%-0.15 | 69.41%-0.52 | 90.00%-0.04 |
| Diluted earnings per share | -25.00%-0.1 | 33.33%-0.04 | 40.00%-0.09 | 46.15%-0.28 | 108.05%0.0032 | 72.41%-0.08 | -140.00%-0.06 | 57.14%-0.15 | 69.41%-0.52 | 90.00%-0.04 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data